Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAP1AP is a pseudogene corresponding to the functional gene RAP1A, a member of the Ras oncogene family. Unlike the functional RAP1A gene, RAP1AP does not code for an active protein and does not serve as a molecular target (receptor, enzyme, etc.) in therapeutic or biological contexts. Its existence reflects a nonfunctional copy of the original gene, and it has no known biological functions, disease associations, or therapeutic relevance[1][2]. RAP1AP (pseudogene) should not be confused with RAP1A (Ras-related protein Rap-1A / KREV1), which is a small GTPase involved in signal transduction, cell adhesion, and cell proliferation, and is a bona fide molecular target with established biological and disease roles[3][4][7][9]. RAP1AP, by contrast, is not a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAP1A, member of RAS oncogene family pseudogene (RAP1AP).